Adjuvant trastuzumab not thought to add to cardiotoxicity

被引:0
|
作者
机构
关键词
Trastuzumab; Anthracycline; Diastolic Dysfunction; Radial Strain; Chemotherapy Group;
D O I
10.2165/00128415-201013090-00007
中图分类号
学科分类号
摘要
引用
收藏
页码:3 / 3
相关论文
共 50 条
  • [31] Fcγ-receptor IIa polymorphism and cardiotoxicity in patients with breast cancer treated with adjuvant trastuzumab.
    Cresti, N.
    Jamieson, D.
    Verrill, M. W.
    Pinkilgton, M.
    Boddy, A. V.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [32] Meta-analysis of adjuvant trastuzumab for early breast cancer: Cardiotoxicity and brain metastases incidence
    Cuppone, F.
    Bria, E.
    Giannarelli, D.
    Nistico, C.
    Sperduti, I.
    Carlini, P.
    Milella, M.
    Ciccarese, M.
    Cognetti, F.
    Terzoli, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [34] Trastuzumab and cardiotoxicity: Weighing the risks
    Wong, SF
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2006, 63 (06) : 525 - 525
  • [35] Cardiotoxicity of trastuzumab in clinical practice
    McArthur, Heather L.
    Chia, Stephen
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (01): : 94 - 95
  • [36] Trastuzumab-Induced Cardiotoxicity
    Stegall, Lisa
    Starbuck, Mandy Fields
    Mayer, Deborah K.
    Harwood, Elaine Brooks
    Glotzer, Jana
    ONCOLOGY NURSING FORUM, 2009, 36 (06) : 676 - 685
  • [39] Trastuzumab-associated cardiotoxicity
    Keefe, DL
    CANCER, 2002, 95 (07) : 1592 - 1600
  • [40] Right Ventricular Dysfunction is Common in Patients With Breast Cancer Experiencing Cardiotoxicity During Adjuvant Trastuzumab Therapy
    Calleja, Anna
    Poulin, Frederic
    McDonald, Michael
    Delgado, Diego H.
    Thavendiranathan, Paaladinesh
    CIRCULATION, 2013, 128 (22)